Previous studies have shown that young patients with lung cancer have a lower incidence of epidermal growth factor receptor (EGFR) mutations and a higher incidence of anaplastic lymphoma kinase (ALK) fusions [5–11], but not all studies have reported the same results [12, 13]. This evidence concerns the gene ALK and lung cancer.